Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

The Fibrin Patch Soft Tissue Study

ClinicalTrials.gov ID: NCT00658723

Public ClinicalTrials.gov record NCT00658723. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 6:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Controlled, Superiority Evaluation of Fibrin Patch as an Adjunct to Control Soft Tissue Bleeding During Abdominal, Retroperitoneal, Pelvic, and Thoracic Surgery

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The effectiveness objective of this study is to evaluate whether Fibrin Patch is superior to SURGICEL™ as an adjunct to achieving hemostasis during surgical procedures involving soft tissue bleeding in abdominal, pelvic, retroperitoneal and (non-cardiac) thoracic surgery.

Study identification

NCT ID
NCT00658723
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ethicon, Inc.
Industry
Enrollment
141 participants

Conditions and interventions

Conditions

Interventions

Drug · Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2008 (Type not available)
Primary completion
Apr 2009 (Actual)
Completion
May 2009 (Actual)
Last update posted
Sep 11, 2014

2008 – 2009

United States locations

U.S. sites
11
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
University of Alabama Birmingham Alabama 35294 —
Jacksonville Center for Clinical Research Jacksonville Florida 32216 —
Baptist Hosptial Miami Florida 33173 —
Emory University Hospital Atlanta Georgia 30322 —
Medical College of Georgia Augusta Georgia 30912 —
University of Maryland Medical Center Baltimore Maryland 21201 —
St. Agnes Healthcare, Inc. Baltimore Maryland 21229 —
Long Island Jewish Medical Center New Hyde Park New York 11040 —
Lehigh Valley Hospital Allentown Pennsylvania 18103 —
The University of Texas MD Anderson Cancer Center Houston Texas 77030 —
Weill Medical Colleges of Cornell University - Methodist Hospital Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00658723, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 11, 2014 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00658723 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →